First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Short Interest Update

First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) saw a large growth in short interest in the month of September. As of September 15th, there was short interest totaling 45,115 shares, a growth of 81.5% from the August 31st total of 24,861 shares. Based on an average daily volume of 28,782 shares, the days-to-cover ratio is currently 1.6 days. Approximately 0.4% of the company’s shares are sold short.

First Trust NYSE Arca Biotechnology Index Fund Stock Performance

NYSEARCA FBT traded down $0.78 during trading on Tuesday, hitting $272.58. The stock had a trading volume of 37,616 shares, compared to its average volume of 112,468. First Trust NYSE Arca Biotechnology Index Fund has a one year low of $176.75 and a one year high of $275.02. The stock has a 50 day simple moving average of $261.97 and a 200 day simple moving average of $233.18. The stock has a market capitalization of $2.97 billion, a price-to-earnings ratio of 21.72 and a beta of 0.67.

Institutional Investors Weigh In On First Trust NYSE Arca Biotechnology Index Fund

A number of institutional investors and hedge funds have recently modified their holdings of the business. Continuum Advisory LLC bought a new position in First Trust NYSE Arca Biotechnology Index Fund in the 2nd quarter valued at $35,000. AG Campbell Advisory LLC bought a new stake in shares of First Trust NYSE Arca Biotechnology Index Fund during the fourth quarter worth $31,000. Cassaday & Co Wealth Management LLC purchased a new stake in shares of First Trust NYSE Arca Biotechnology Index Fund during the first quarter valued at $34,000. Parallel Advisors LLC boosted its stake in shares of First Trust NYSE Arca Biotechnology Index Fund by 1,300.0% during the first quarter. Parallel Advisors LLC now owns 182 shares of the company’s stock valued at $37,000 after purchasing an additional 169 shares during the period. Finally, Capital Analysts LLC boosted its stake in shares of First Trust NYSE Arca Biotechnology Index Fund by 39.3% during the second quarter. Capital Analysts LLC now owns 227 shares of the company’s stock valued at $56,000 after purchasing an additional 64 shares during the period.

About First Trust NYSE Arca Biotechnology Index Fund

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.